5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole

C136H162N18O18 — CID 159906184

IUPAC5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole
SMILESCCOc1ccc(-c2nc(-c3ccc(CN(C)C)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3C)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN(C)C)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3C)no2)cc1OCC
InChIInChI=1S/2C24H29N3O3.2C23H27N3O3.2C21H25N3O3/c1-4-28-21-11-9-19(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-18(14-17(20)3)16-27-12-6-7-13-27;1-4-28-21-12-11-18(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-9-19(17(20)3)16-27-13-6-7-14-27;1-3-27-20-12-11-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-17(8-10-18)16-26-13-5-6-14-26;1-3-27-20-11-10-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-8-17(14-18)16-26-12-5-6-13-26;1-5-25-18-12-11-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-15(8-10-16)14-24(3)4;1-5-25-18-11-10-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-8-15(12-16)14-24(3)4/h8-11,14-15H,4-7,12-13,16H2,1-3H3;8-12,15H,4-7,13-14,16H2,1-3H3;7-12,15H,3-6,13-14,16H2,1-2H3;7-11,14-15H,3-6,12-13,16H2,1-2H3;2*7-13H,5-6,14H2,1-4H3
InChIKeyNWPGNURULGAVDV-UHFFFAOYSA-N
MW2336.90 g/mol
LogP28.33
Rot. Bonds48

About 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole

5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole (PubChem CID 159906184) has the molecular formula C136H162N18O18 and a molecular weight of 2336.90 g/mol. Its IUPAC name is 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole
PubChem CID159906184
Molecular FormulaC136H162N18O18
Molecular Weight2336.90 g/mol
Exact Mass2335.23
IUPAC Name5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole
SMILESCCOc1ccc(-c2nc(-c3ccc(CN(C)C)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3C)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN(C)C)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3C)no2)cc1OCC
InChIInChI=1S/2C24H29N3O3.2C23H27N3O3.2C21H25N3O3/c1-4-28-21-11-9-19(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-18(14-17(20)3)16-27-12-6-7-13-27;1-4-28-21-12-11-18(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-9-19(17(20)3)16-27-13-6-7-14-27;1-3-27-20-12-11-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-17(8-10-18)16-26-13-5-6-14-26;1-3-27-20-11-10-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-8-17(14-18)16-26-12-5-6-13-26;1-5-25-18-12-11-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-15(8-10-16)14-24(3)4;1-5-25-18-11-10-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-8-15(12-16)14-24(3)4/h8-11,14-15H,4-7,12-13,16H2,1-3H3;8-12,15H,4-7,13-14,16H2,1-3H3;7-12,15H,3-6,13-14,16H2,1-2H3;7-11,14-15H,3-6,12-13,16H2,1-2H3;2*7-13H,5-6,14H2,1-4H3
InChIKeyNWPGNURULGAVDV-UHFFFAOYSA-N
XLogP28.33
TPSA363.72 Ų
H-Bond Donors
H-Bond Acceptors36
Rotatable Bonds48
Heavy Atoms172
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002336.90
LogP ≤ 528.33
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1036

Analyze 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The IUPAC name of 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole (CID 159906184) is 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole.
What is the SMILES notation for 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The canonical SMILES for 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole is CCOc1ccc(-c2nc(-c3ccc(CN(C)C)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3ccc(CN4CCCC4)cc3C)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN(C)C)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3)no2)cc1OCC.CCOc1ccc(-c2nc(-c3cccc(CN4CCCC4)c3C)no2)cc1OCC.
What is the InChIKey of 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The InChIKey is NWPGNURULGAVDV-UHFFFAOYSA-N. The full InChI is InChI=1S/2C24H29N3O3.2C23H27N3O3.2C21H25N3O3/c1-4-28-21-11-9-19(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-18(14-17(20)3)16-27-12-6-7-13-27;1-4-28-21-12-11-18(15-22(21)29-5-2)24-25-23(26-30-24)20-10-8-9-19(17(20)3)16-27-13-6-7-14-27;1-3-27-20-12-11-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-17(8-10-18)16-26-13-5-6-14-26;1-3-27-20-11-10-19(15-21(20)28-4-2)23-24-22(25-29-23)18-9-7-8-17(14-18)16-26-12-5-6-13-26;1-5-25-18-12-11-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-15(8-10-16)14-24(3)4;1-5-25-18-11-10-17(13-19(18)26-6-2)21-22-20(23-27-21)16-9-7-8-15(12-16)14-24(3)4/h8-11,14-15H,4-7,12-13,16H2,1-3H3;8-12,15H,4-7,13-14,16H2,1-3H3;7-12,15H,3-6,13-14,16H2,1-2H3;7-11,14-15H,3-6,12-13,16H2,1-2H3;2*7-13H,5-6,14H2,1-4H3.
What are the key properties of 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole has a molecular weight of 2336.90 g/mol, XLogP of 28.33, 48 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(3,4-diethoxyphenyl)-3-[2-methyl-3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[2-methyl-4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;1-[3-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;1-[4-[5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-N,N-dimethylmethanamine;5-(3,4-diethoxyphenyl)-3-[3-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole;5-(3,4-diethoxyphenyl)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-1,2,4-oxadiazole is sourced from PubChem (CID 159906184), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).